摘要
目的探讨miR-497对恶性脑膜瘤细胞增殖的影响及作用机制。方法收集2019年1~9月手术切除的女性脑膜瘤组织标本10例,其中恶性脑膜瘤5例(WHO分级Ⅲ级),良性脑膜瘤5例(WHO分级Ⅰ级),采用RNA-seq法和qRT-PCR检测脂肪酸合成酶(FASN)mRNA和miR-497表达水平。体外培养恶性脑膜瘤细胞株IOMM-Lee细胞,设置空白组(不做任何处理)、miR-NC组(转染negative control质粒)、miR-497-m组(转染miR-497 mimics)和miR-497-i组(转染miR-497 inhibitor),MTT法检测细胞增殖能力,检测细胞上清液乳酸水平和细胞ATP含量,免疫印迹法检测细胞FASN蛋白表达水平。结果恶性脑膜瘤组织FASN mRNA水平明显高于良性脑膜瘤组织(P<0.05),而miR-497水平则明显低于良性脑膜瘤组织(P<0.05)。与空白组和miR-NC组相比,miR-497-m组细胞增殖能力、细胞上清液乳酸水平、细胞ATP含量以及FASN蛋白表达水平均明显降低(P<0.05);而miR-497-i组细胞增殖能力、细胞上清液乳酸水平、细胞ATP含量以及FASN蛋白表达水平均明显升高(P<0.05)。结论恶性脑膜瘤组织miR-497呈低表达,通过靶向促进FASN表达,提高肿瘤细胞内脂肪酸代谢水平,促进肿瘤细胞增殖。
Objective To investigate the effect of miR-497 on the proliferation of malignant meningioma cells and its mechanism.Methods The levels of fatty acid synthase(FASN)mRNA and miR-497 were detected by RNA-seq and qRT-PCR in meningioma tissues obtained from 10 female patients with meningioma including 5 malignant and 5 benign meningiomas.IOMM-Lee cells were cultured in vitro and divided into blank group,miR-NC group(transfected with negative control),miR-497-m group(transfected with miR-497 mimics)and miR-497-i group(transfected with miR-497 inhibitor).The cell proliferation ability was detected by MTT method;lactic acid in cell supernatant and cell ATP contents were detected;FASN protein expression were measured using western blotting.Results The mRNA level of FASN was signifcantly higher and the miR-497 level was signifcantly lower in malignant meningioma tissues than benign meningioma tissues(P<0.05).Compared with blank and miR-NC groups,the cell proliferation activity,lactate acid level in the cell supernatant,cell ATP content and FASN protein expression level significantly decreased in miR-497-m group(P<0.05),while significantly increased in miR-497-i group(P<0.05).Conclusion The expression level of miR-497 in malignant meningioma tissue is low,which may be by promoting FASN expression and increasing the fatty acid metabolism level in tumor cells to promote tumor cell proliferation.
作者
周德才
王少雄
黄程
王文波
ZHOU De-cai;WANG Shao-xiong;HUANG Cheng;WANG Wen-bo(Department of Neurosurgery,Haikou Third People's Hospital,Haikou 571100,China;Department of Neurosurgery,Affiliated Hospital of Guilin Medical College,Guilin 541001,China)
出处
《中国临床神经外科杂志》
2021年第2期106-109,共4页
Chinese Journal of Clinical Neurosurgery